+1 (629)348-3199Short Communication - Gynecology and Reproductive Endocrinology (2020) Volume 4, Issue 3
Cellular matrix, medical device for treating female sexual dysfunction
WHO describes sexuality as a central aspect of being human throughout life, yet there are so many sexual dysfunctions between men and women. Prevalence of female sexual dysfunction ranges from 25-63% and in postmenopausal women it is well over 80%. These conditions are frequently underdiagnosed and undertreated. Women find it difficult to talk about it. Many women are unaware that symptoms progress without treatment and that safe and effective treatment are available.
Author(s): Ksenija Selih Martinec